Tern Plc Online Investor Presentation and Q&A Session

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has announced that it will be hosting an online presentation and Q&A session at 5.30 p.m. GMT on Tuesday 21 November 2023.

Presenting will be members of Tern’s management team and management from Tern’s portfolio companies Device Authority, Wyld Networks and Talking Medicines. This session is open to all existing and prospective shareholders. Those who wish to attend should register via the following link where they will be provided with access details:

https://us02web.zoom.us/webinar/register/WN_Uouqd7FASNCpmPC1JS1QAQ

Participants will have the opportunity to submit questions for Tern plc during the session, but questions are welcomed in advance and may be submitted prior to 3 p.m. GMT on 21 November 2023 to: tern@investor-focus.co.uk.

Share on:

You might also enjoy reading Rethinking AI for pharmaceutical insight

Written by: Ethan Davis

Find more news, interviews, share price & company profile here for:
Tern Plc

Latest Company News

Tern Plc publishes presentations from Device Authority and Talking Medicines investor event

January 8, 2026

Tern Plc has released copies of the presentations delivered by portfolio companies Device Authority and Talking Medicines during its recent online investor presentation and Q&A session.

India and China push automotive cybersecurity in a new direction

January 7, 2026

India and China are setting new rules for automotive cybersecurity, and the manufacturers that keep up will be the ones that stay in the game.

Pharma faces a strategic turning point in AI adoption

December 17, 2025

AI in pharma is moving from operational support to strategic driver as companies prioritise messaging that delivers measurable prescriber impact.

Tern Plc updates position in Talking Medicines with new convertible loan notes

December 12, 2025

Tern Plc has received about £230,000 in new unsecured convertible loan notes from Talking Medicines after cancelling around £180,000 of short term loans provided over 2024 and 2025.

The real problem holding back connected vehicle programmes

December 10, 2025

Vehicle identity is fast becoming a core infrastructure challenge, and a new bottleneck for OEMs aiming to scale software-defined platforms.

Talking Medicines is building the AI layer beneath pharma marketing

December 3, 2025

Talking Medicines is shifting pharma marketing from content creation to data control, building the layer AI tools rely on to deliver credible, measurable clinical messaging.